Topic: contract research organizations
The CRO just took in Continuum Clinical’s Late Stage research practice and folded it into its Evidence business unit.
Citoxlab is looking to boost its position among Europe’s top nonclinical CROs by buying up Solvo Biotechnology.
The CRO will transfer most of its Pennsylvania-based biologics laboratory functions to a new, 73,000-square-foot site on Devon Park in Wayne.
The new team brings together the CRO’s existing expertise in flow cytometry, immunoassays, cell-based assays and immunotoxicology.
Big Pharma Novartis is teaming up with virtual clinical trial company Science 37 to boost the Swiss major’s ability to run “site-less” studies.
As biopharmas struggle to recruit patients for clinical trials, PPD and Acurian are hoping to make the process easier with a new “concierge service.”
CMIC will be able to access Median’s imaging technologies, services and imaging expertise to support its clients' cancer studies.
SenzaGen says its in vitro models can predict chemicals at risk of causing allergies better than predominant tests in mice.
Charles River Laboratories snatches up nonclinical CRO MPI Research for $800 million in cash.
Preclinical CRO Sinclair Research has carved out a new role for G. Alex Wakefield as he becomes its vice president of research and operations.